Le Lézard
Classified in: Health, Science and technology
Subjects: CCA, FVT

West to Host Second-Quarter 2020 Conference Call


EXTON, Pa., July 9, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2020 financial results before the market opens on Thursday, July 23, 2020, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call, please dial 877-930-8295 (U.S.) or 253-336-8738 (International). The conference ID is 7789173.

A live broadcast of the conference call will be available at the Company's website, www.westpharma.com, in the "Investors" section. Management will refer to a slide presentation during the call, which will be made available on the day of the call. To view the presentation, select "Presentations" in the "Investors" section of the Company's website.  

An online archive of the broadcast will be available at the site three hours after the live call and will be available through Thursday, July 30, 2020, by dialing 855-859-2056 (U.S.) or 404-537-3406 (International). The conference ID is 7789173.

About West

West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2019 sales of $1.84 billion reflect the daily use of more than 100 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

 

SOURCE West Pharmaceutical Services, Inc.


These press releases may also interest you

at 07:35
Endeavor BioMedicines, Inc. ("Endeavor"), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, today announced the closing of a $132.5...

at 07:35
PROG Holdings, Inc. , the fintech holding company for Progressive Leasing, Vive Financial, Four Technologies, and Build, today announced financial results for the first quarter ended March 31, 2024. "We're pleased with our strong start to the year,...

at 07:35
Vecima Networks Inc. announced today that Dell'Oro Group has recognized the company as the 2023 market share leader in two Distributed Access Architecture (DAA) segments ? Remote Optical Line Terminals (R-OLT) and Remote MACPHY (R-MACPHY). Dell'Oro...

at 07:35
Fortive Corporation ("Fortive") today announced financial results for the first quarter of 2024. For the first quarter, net earnings were $207 million. For the same period, adjusted net earnings were $295 million, which excludes the $63 million...

at 07:30
Bitech Technologies Corporation [OTCQB: BTTC], ("the Company" or "Bitech"), a technology solution provider dedicated to green energy solutions, is pleased to announce that it has completed the previously announced acquisition of Emergen Energy LLC...

at 07:30
The enterprise web developer, Interfuse has made an important update to their Knowledge Base application which provides detailed Revision History for subject matters published on their platform. The Revision History link can be found below the...



News published on and distributed by: